Takara Bio Inc (4974)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Takara Bio Inc (4974) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011539
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments. The company sells gene amplification system and offers scientific instruments. Takara also provides contract research services. It develops and commercializes medical technologies such as cell and gene therapies for cancer and AIDS. The company produces and sells hatakeshimeji and honshimeji mushrooms. It supports biotechnology research by offering basic research and drug discovery and development services. Takara is headquartered in Kusatsu, Japan.

Takara Bio Inc (4974) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Takara Bio Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Takara Bio Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Takara Bio Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Takara Bio Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Takara Bio Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Takara Bio Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Rubicon Genomics Raises USD2 Million in Venture Financing 12
Partnerships 13
Rubicon Genomics Enters Into Licensing Agreement With University Of Michigan 13
WaferGen Bio-systems Enters into Distribution Agreement with Takara Bio 14
Takara Bio Enters into Agreement with Integrated DNA Technologies 15
WaferGen Biosystems Enters into Research Agreement with Women’s College Research Institute 16
Rubicon Genomics Enters Into Distribution Agreement With GenoMax Technologies For DNA Library Prep Kits 17
Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 18
WaferGen Biosystems Enters Into Co-Marketing Agreement With Qiagen 19
Takara Bio Enters Into Co-Marketing Agreement With Pathogenica For HAI Sequencing Service 20
WaferGen Biosystems Enters Into Agreement With Integrated DNA Technologies 21
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 22
Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics 23
New England Biolabs Enters Into Co-Marketing Agreement With Rubicon Genomics 24
PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 25
Takara Bio Forms Joint Venture With DSS Imagetech 26
Takara Bio Enters Into Licensing Agreement With InVivoScribe Technologies For FLT3-ITD 27
Eppendorf Enters Into Licensing Agreement With Takara Bio 28
Equity Offering 29
WaferGen Bio-systems Raises USD17.25 Million in Public Offering of Common Stock 29
Takara Bio Raises USD112 Million in Public Offering Of Common Stock 30
Acquisition 31
Takara Bio Acquires WaferGen Bio-Systems 31
Takara Bio Acquires Rubicon Genomics for USD75 Million 33
Takara Bio Inc – Key Competitors 34
Takara Bio Inc – Key Employees 35
Takara Bio Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Joint Venture 37
Recent Developments 38
Financial Announcements 38
Nov 28, 2017: Takara Bio: Consolidated Financial Statements for the Second Quarter Ended September 30, 2017 38
May 09, 2016: Takara Bio: Consolidated Financial Statements for the Year Ended March 31 40
Product News 43
Feb 29, 2016: Clontech Laboratories Releases TaKaRa Taq Hot Start Version GMP Grade 43
Jan 25, 2016: Release of GMP grade PCR enzyme for genetic diagnosis 44
Other Significant Developments 45
Jun 06, 2016: WaferGen Bio-systems and Takara Bio Announce Exclusive Distribution Agreement for Japan 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Takara Bio Inc, Medical Equipment, Key Facts, 2017 2
Takara Bio Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Takara Bio Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Takara Bio Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Takara Bio Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Takara Bio Inc, Deals By Market, 2011 to YTD 2017 9
Takara Bio Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Rubicon Genomics Raises USD2 Million in Venture Financing 12
Rubicon Genomics Enters Into Licensing Agreement With University Of Michigan 13
WaferGen Bio-systems Enters into Distribution Agreement with Takara Bio 14
Takara Bio Enters into Agreement with Integrated DNA Technologies 15
WaferGen Biosystems Enters into Research Agreement with Women's College Research Institute 16
Rubicon Genomics Enters Into Distribution Agreement With GenoMax Technologies For DNA Library Prep Kits 17
Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 18
WaferGen Biosystems Enters Into Co-Marketing Agreement With Qiagen 19
Takara Bio Enters Into Co-Marketing Agreement With Pathogenica For HAI Sequencing Service 20
WaferGen Biosystems Enters Into Agreement With Integrated DNA Technologies 21
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 22
Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics 23
New England Biolabs Enters Into Co-Marketing Agreement With Rubicon Genomics 24
PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 25
Takara Bio Forms Joint Venture With DSS Imagetech 26
Takara Bio Enters Into Licensing Agreement With InVivoScribe Technologies For FLT3-ITD 27
Eppendorf Enters Into Licensing Agreement With Takara Bio 28
WaferGen Bio-systems Raises USD17.25 Million in Public Offering of Common Stock 29
Takara Bio Raises USD112 Million in Public Offering Of Common Stock 30
Takara Bio Acquires WaferGen Bio-Systems 31
Takara Bio Acquires Rubicon Genomics for USD75 Million 33
Takara Bio Inc, Key Competitors 34
Takara Bio Inc, Key Employees 35
Takara Bio Inc, Subsidiaries 36
Takara Bio Inc, Joint Venture 37

★海外企業調査レポート[Takara Bio Inc (4974)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nexter Group:企業の戦略・SWOT・財務情報
    Nexter Group - Strategy, SWOT and Corporate Finance Report Summary Nexter Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Teco Energy Inc:企業の戦略的SWOT分析
    Teco Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Shenzhen Moso Power Supply Technology Co Ltd (002660):電力:M&Aディール及び事業提携情報
    Summary Shenzhen Moso Power Supply Technology Co Ltd (Moso Power) is a manufacturer of electronics and electrical appliances. The company designs and distributes consumer electronics and solar photovoltaic products. Its products include LED driver, outdoor lighting, industrial lighting, landscape li …
  • Response Biomedical Corp:企業の戦略的SWOT分析
    Response Biomedical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Alcon Inc (ALC):企業の製品パイプライン分析
    Summary Alcon Inc (Alcon) develops and manufactures devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables and surgical equipment. The company's products are indicated for the treatment of various condition …
  • Naspers Limited:企業の戦略・SWOT・財務分析
    Naspers Limited - Strategy, SWOT and Corporate Finance Report Summary Naspers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Perrigo Co Plc (PRGO):企業の財務・戦略的SWOT分析
    Perrigo Co Plc (PRGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • GridPoint, Inc.-エネルギー分野:企業M&A・提携分析
    Summary GridPoint, Inc. (Gridpoint), a subsidiary of Twenty First Century Utilities LLC, is a provider of data-driven energy management systems. The company offers a wide range of energy management hardware including control, equipment-level sub-metering and advanced monitoring devices such as contr …
  • DLF Limited:企業の戦略・SWOT・財務情報
    DLF Limited - Strategy, SWOT and Corporate Finance Report Summary DLF Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Novaliq GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations. The company develops novel ophthalmic and dermatological products, and solutions for organ preservation based on the physicochemical properties of semifluorinated alkanes. It offers NovaTears, a pres …
  • Mindray Medical International Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Mindray Medical International Ltd (Mindray Medical) is a developer, manufacturer and marketer of medical devices and solutions. The company offers products for patient monitoring and life support, in-vitro diagnostics, veterinary, and medical imaging systems. Its major products include patie …
  • Banco do Brasil SA:戦略・SWOT・企業財務分析
    Banco do Brasil SA - Strategy, SWOT and Corporate Finance Report Summary Banco do Brasil SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PhoenixBio Co Ltd (6190):企業の財務・戦略的SWOT分析
    Summary PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services including dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and blo …
  • PLT Health Solutions Inc:企業の戦略・SWOT・財務分析
    PLT Health Solutions Inc - Strategy, SWOT and Corporate Finance Report Summary PLT Health Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Shopper’s Stop Ltd.:戦略・SWOT・企業財務分析
    Shopper's Stop Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shopper's Stop Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ViacomCBS Inc (VIAC):企業の財務・戦略的SWOT分析
    ViacomCBS Inc (VIAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • InCarda Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InCarda Therapeutics Inc (InCarda) is a biopharmaceutical company that concentrates on the development of transformative therapies for cardiovascular conditions through the inhalation route. The company’s lead product candidate includes InRhythm, an inhaled antiarrhythmic for acute treatment …
  • Goa Shipyard Ltd:企業の戦略・SWOT・財務分析
    Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report Summary Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Veracyte Inc (VCYT):企業の財務・戦略的SWOT分析
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products comprise Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It als …
  • King Yuan Electronics Co Ltd (2449):企業の財務・戦略的SWOT分析
    King Yuan Electronics Co Ltd (2449) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆